Novartis stock price improved significantly yesterday reaching over $98 a share. However many analysts have been quick to point out that several of the company's new drugs are held up in regulatory delays and the projected sales out for 2021 is worse than previously expected. Look for a corrective drop in Novartis stock when U.S. market open today.
No comments:
Post a Comment